文献速递流行病学与生物统计

生存结局下数据自适应双重稳健估计的统计推断

Statistical inference for data-adaptive doubly robust estimators with survival outcomes.
PubMed 文献 · Stat Med · 2019-04-04

本文提出一种用于生存分析的双重稳健估计方法,在仅要求至少一个干扰参数以n^(1/4)速率一致估计的条件下,该估计量以n^(1/2)速率收敛于高斯变量,适用于一大类数据自适应干扰估计量。文中给出渐近方差公式以计算双重稳健置信区间和P值,通过模拟研究展示有限样本性质,并在一项针对人表皮生长因子受体2(HER2)阳性乳腺癌新疗法的III期临床试验中演示其应用。

要点

  • 新估计量在至少一个干扰参数以n^(1/4)速率一致估计时,以n^(1/2)速率收敛于高斯变量。
  • 通过高斯化漂移项和交叉拟合避免熵条件,实现数据自适应干扰估计下的双重稳健推断。
  • 给出渐近方差公式,可计算双重稳健置信区间和P值。

核心结论

  • 所提出的双重稳健估计量在仅要求至少一个干扰参数以n^(1/4)速率一致估计的条件下,以n^(1/2)速率收敛于高斯变量,适用于一大类数据自适应干扰估计量。

研究设计与样本

  • 方法学研究,提出生存分析的双重稳健估计量并推导其渐近性质,通过模拟研究评估有限样本性质,并在一项III期临床试验中演示应用。

主要发现

  • 估计量在至少一个干扰参数以n^(1/4)速率一致估计时以n^(1/2)速率收敛于高斯变量。
  • 通过高斯化漂移项和交叉拟合避免了对干扰估计量的熵条件。
  • 给出了渐近方差公式,可用于计算双重稳健置信区间和P值。
  • 模拟研究展示了估计量的有限样本性质。
  • 在针对HER2阳性乳腺癌新疗法的III期临床试验中演示了估计量的应用。

局限性

  • 原文未报告局限性

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

The consistency of doubly robust estimators relies on the consistent estimation of at least one of two nuisance regression parameters. In moderate-to-large dimensions, the use of flexible data-adaptive regression estimators may aid in achieving this consistency. However, n1/2 -consistency of doubly robust estimators is not guaranteed if one of the nuisance estimators is inconsistent. In this paper, we present a doubly robust estimator for survival analysis with the novel property that it converges to a Gaussian variable at an n1/2 -rate for a large class of data-adaptive estimators of the nuisance parameters, under the only assumption that at least one of them is consistently estimated at an n1/4 -rate. This result is achieved through the adaptation of recent ideas in semiparametric inference, which amount to (i) Gaussianizing (ie, making asymptotically linear) a drift term that arises in the asymptotic analysis of the doubly robust estimator and (ii) using cross-fitting to avoid entropy conditions on the nuisance estimators. We present the formula of the asymptotic variance of the estimator, which allows for the computation of doubly robust confidence intervals and p values. We illustrate the finite-sample properties of the estimator in simulation studies and demonstrate its use in a phase III clinical trial for estimating the effect of a novel therapy for the treatment of human epidermal growth factor receptor 2 (HER2)-positive breast cancer.

来源:Stat Med,查看原文。版权归原作者所有。

引用

  1. Díaz I. Statistical inference for data-adaptive doubly robust estimators with survival outcomes. Stat Med. 2019. PMID: 30950107. doi:10.1002/sim.8156

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。